易普力(002096.SZ):民爆物品主要原材料價格整體趨於穩定
格隆匯9月8日丨有投資者向易普力(002096.SZ)提問:如何應對原材料價格上升、產品運輸成本增加等因素對利潤的影響?
易普力回覆:您好!今年以來,民爆物品主要原材料價格整體趨於穩定,同比略有下降。根據中國爆破器材行業協會《工作簡報》數據,截至今年6月末,工業炸藥主要原材料硝酸銨的價格同比下降8.36%-9.75%;公司將持續發揮集採優勢,實現採購渠道的集中管理和分類共享,並構建戰略採購體系,推進供應商渠道開發,確保供應鏈安全與穩定。關於運輸成本方面,運輸成本佔比較小,公司積極搭建長期協作運輸服務商體系,依託公司的規模化優勢,優化運輸路線,減少運輸成本。感謝您對公司的關注。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.